Literature DB >> 10637554

Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis.

B Balasa1, N Sarvetnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10637554     DOI： 10.1016/s0167-5699(99)01553-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  4 in total

1.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide.

Authors:  Marc Weeber; Rein Vos; Henny Klein; Lolkje T W De Jong-Van Den Berg; Alan R Aronson; Grietje Molema
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

3.  Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.

Authors:  Jie Luo; Alexander Kuryatov; Jon M Lindstrom
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

4.  Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes.

Authors:  G Aust; D Sittig; M Steinert; P Lamesch; T Lohmann
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.